Abstract:Abstract Mesenchymal stem cells (MSCs) are associated with pulmonary protection and longevity. We separated chicken bone marrow-derived mesenchymal stem cells (BM-MSCs); investigated whether BM-MSCs can improve lipopolysaccharide (LPS)-induced lung and distal organ injury; and explored the underlying mechanisms. Ninety-six male ICR (6 weeks old) mice were randomly divided into three groups: Sham, LPS, and LPS + MSC groups. The mice were intratracheally injected with 5 mg/kg LPS to induce acute lung injury (ALI). The histopathological severity of injury to the lung, liver, kidney, heart, and aortic tissues was detected. Wet/dry ratio, protein concentrations in bronchoalveolar lavage fluid (BALF), BALF cell counts, inflammatory cytokine levels in serum, inflammatory cytokine gene expression, and oxidative stress-related indicators were detected. In addition, a survival analysis was performed in sixty male ICR mice (6 weeks old, 18–20 g). This study used chicken BM-MSCs, which are easier to obtain and more convenient than other animal or human MSCs, and have MSC-associated properties, such as a colony forming ability, multilineage differentiation potential, and certain phenotypes. BM-MSCs administration significantly improved the survival rate, systemic inflammation, and the histopathological severity of lung, liver, kidney, and aortic injury during ALI. BM-MSCs administration reduced the levels of inflammatory factors in BALF, the infiltration of neutrophils, and oxidative stress injury in lung tissue. In addition, BM-MSCs administration reduced TRL4 and Mdy88 mRNA expression during ALI. Chicken BM-MSCs serve as a potential alternative resource for stem cell therapy and exert a prominent effect on LPS-induced ALI and extrapulmonary injury, in part through TRL4/Mdy88 signaling and inhibition of neutrophil inflammation and oxidative stress injury.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether chicken bone marrow - derived mesenchymal stem cells (BM - MSCs) can ameliorate acute lung injury (ALI) induced by lipopolysaccharide (LPS) and distal organ injury, and to explore its underlying mechanisms. Specifically, the study aims to verify whether BM - MSCs can prevent ALI and the distal organ injury caused by it by regulating inflammatory parameters and oxidative stress indices. ### Research Background - **Acute Lung Injury (ALI)**: ALI is a disease characterized by increased lung permeability and intensified inflammatory response, often leading to diffuse alveolar damage, pulmonary edema, hypoxemia and respiratory failure, with a relatively high mortality rate. - **Inflammatory Response**: The pathogenesis of ALI is complex, and excessive inflammatory response plays a key role in it. Inflammatory mediators such as IL - 1β and TNF - α, as well as effector cells such as neutrophils, play important roles in the inflammatory response. - **Neutrophils**: Neutrophils release a variety of factors, such as matrix metalloproteinase 9 (MMP - 9) and transforming growth factor - β (TGF - β), which may lead to pulmonary fibrosis and distal organ injury. - **Toll - like Receptor 4 (TLR4)/Myeloid Differentiation Factor 88 (MyD88) Signaling Pathway**: LPS activates the TLR4/MyD88 signaling pathway to cause excessive inflammatory response, but the influence of BM - MSCs on this pathway is still unclear. ### Research Objectives - **Verify the Role of BM - MSCs**: To study whether chicken bone marrow - derived mesenchymal stem cells (BM - MSCs) can ameliorate LPS - induced acute lung injury (ALI) and distal organ injury. - **Explore the Mechanisms**: To explore how BM - MSCs exert their protective effects by regulating inflammatory parameters and oxidative stress indices. ### Main Findings - **Survival Rate**: BM - MSCs significantly increased the survival rate of mice with LPS - induced ALI. - **Systemic Inflammation**: BM - MSCs significantly reduced the levels of inflammatory cytokines in serum, such as CXCL - 1, IL - 1β, IL - 8 and TNF - α. - **Oxidative Stress**: BM - MSCs significantly improved the oxidative stress indicators in lung tissues, such as the expressions of SOD, MDA, GSH and MPO. - **Lung Injury**: BM - MSCs significantly alleviated the infiltration of inflammatory cells and interstitial edema in lung tissues. - **Neutrophil Content**: BM - MSCs significantly decreased the neutrophil content in lung tissues. - **Pulmonary Edema**: BM - MSCs significantly reduced the total protein concentration and wet/dry weight ratio (W/D ratio) in lung tissues. - **Inflammatory Gene Expression**: BM - MSCs significantly down - regulated the mRNA expressions of CXCL - 1, IL - 1β, IL - 8 and TNF - α in lung tissues, and simultaneously up - regulated the mRNA expressions of IL - 1RN and IL - 10. - **TLR4/MyD88 Signaling Pathway**: BM - MSCs significantly inhibited the expressions of TLR4 and MyD88 mRNAs induced by LPS. - **Pulmonary Fibrosis**: BM - MSCs significantly down - regulated the mRNA expressions of MMP - 9 and TGF - β in lung tissues and reduced pulmonary fibrosis. - **Distal Organ Injury**: BM - MSCs significantly alleviated the LPS - induced injuries of the aorta, liver, kidney and heart. ### Conclusion Chicken bone marrow - derived mesenchymal stem cells (BM - MSCs) show significant protective effects in LPS - induced acute lung injury (ALI) and distal organ injury. Part of the mechanisms may be related to its inhibition of neutrophil - mediated inflammatory response and oxidative stress through the TLR4/MyD88 signaling pathway. These findings provide a scientific basis for BM - MSCs as a potential resource for stem cell therapy.

Chicken bone marrow mesenchymal stem cells improve lung and distal organ injury